UM Miller School of Medicine: Aman Chauhan Presents Phase 1 Study on Neuroendocrine Tumors at ESMO 2025
October 21, 2025
October 21, 2025
MIAMI, Florida, Oct. 21 -- The University of Miami Miller School of Medicine issued the following news:
* * *
Aman Chauhan Presents Phase 1 Study on Neuroendocrine Tumors at ESMO 2025
Article Summary
* Sylvester Comprehensive Cancer Center's Dr. Aman Chauhan will present new findings from a National Cancer Institute-sponsored phase 1 clinical trial at the European Society for Medical Oncology (ESMO) Congress 2025.
* The study . . .
* * *
Aman Chauhan Presents Phase 1 Study on Neuroendocrine Tumors at ESMO 2025
Article Summary
* Sylvester Comprehensive Cancer Center's Dr. Aman Chauhan will present new findings from a National Cancer Institute-sponsored phase 1 clinical trial at the European Society for Medical Oncology (ESMO) Congress 2025.
* The study . . .